UMIN-CTR History

UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials


Unique ID issued by UMIN UMIN000023761
Receipt No. R000027377
Scientific Title A phase I study of osimertinib with bevacizumab and randomized phase II study of osimertinib with or without bevacizumab in EGFR mutated, T790M positive patients who had progressed EGFR-TKIs. (WJOG8715L)
Date of disclosure of the study information 2016/08/25
Last modified on 2019/08/28 09:50:53

No. Disposal Last modified on Item of update
1 Insert 2016/08/25 14:31:07
2 Update 2016/10/11 10:52:18 Recruitment status
Anticipated trial start date
3 Update 2019/01/28 09:52:32 Recruitment status
4 Update 2019/08/28 09:50:22 Date of IRB
Last follow-up date
5 Update 2019/08/28 09:50:53 Number of participants that the trial has enrolled

Contact us.